We extend our warmest congratulations to Professor Lim Chwee Teck, Principal Investigator at NUS Guangzhou Research Translation and Innovation Institute, on his election as an International Fellow of the Royal Academy of Engineering, United Kingdom. This remarkable achievement follows his earlier election as a Fellow of the Royal Society, making him one of the rare scholars to hold both distinguished honours. His success exemplifies the highest standards of academic excellence and innovation, and we are proud to have him as part of our institute.

Prof Lim Chwee Teck has been recognised for his pioneering research in biomedical engineering, and impactful contributions to advancing disease diagnosis and therapy.

Professor Lim Chwee Teck, Director of the Institute for Health Innovation and Technology at the National University of Singapore (NUS iHealthtech) and NUS Society (NUSS) Professor, has been elected an International Fellow of the Royal Academy of Engineering (FREng) – one of the most prestigious honours in the global engineering community.

The Fellowship of the Royal Academy of Engineering recognises the most accomplished engineers, inventors, and technologists from the United Kingdom and around the world who have made exceptional contributions to engineering. This year, 74 new Fellows were elected by their peers, including nine International and five Honorary Fellows who have demonstrated outstanding impact in their fields.

This latest honour follows Prof Lim’s election to the Royal Society in 2024, highlighting his rare distinction as the first and only Singaporean to be recognised by both of the world’s most prestigious science and engineering academies – a testament to the interdisciplinary impact of his trailblazing work.

Prof Lim, who is also with the Department of Biomedical Engineering under the College of Design and Engineering at NUS, was elected to the Academy in recognition of his pioneering research in biomedical engineering, and his significant contributions to the development of microfluidic and wearable technologies for disease diagnosis and therapy. A globally renowned biomedical engineer, inventor, and entrepreneur, he has translated academic innovations into impactful healthcare solutions through six start-ups, including one that was publicly listed. Among his transformative technologies is a cancer-detecting biochip designed to capture circulating tumour cells from blood, offering a less invasive approach to cancer diagnostics.

In addition to his research and innovation, Prof Lim is deeply dedicated to mentoring the next generation of researchers, actively shaping the future of biomedical engineering and healthcare innovation.

“I’m extremely honoured to be elected a Fellow of the Royal Academy of Engineering, and incredibly proud to be the only Singaporean elected to both the Royal Academy and also the Royal Society,” said Prof Lim. “This recognition is a reflection of the hard work and creativity of my amazing team of past and present lab members, as well as the many outstanding collaborators whom I have the privilege to work with. I am also grateful to the Academy for this profound honour, and will remain committed to using engineering to create real-world impact.”

Prof Lim’s election to both academies reflects the rising global stature of Singaporean science and engineering, and highlights how interdisciplinary innovation is shaping the future of healthcare.

Please refer to the Royal Academy's announcement here, and Prof Lim’s Royal Academy Fellow profile page here.

Source: NUS NEWS